Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection

J Infect Dis. 2010 Aug 15;202(4):633-7. doi: 10.1086/654813.

Abstract

Radioimmunotherapy (RIT) prolongs the survival of mice infected with Cryptococcus neoformans. To compare the efficacy of RIT with that of amphotericin B, we infected AJ/Cr mice intravenously with either nonmelanized or melanized C. neoformans cells. Infected mice were either left untreated or treated 24 h after infection with (213)Bi-18B7 antibody, amphotericin B, or both. Melanization before infection did not increase resistance of C. neoformans to RIT in vivo. (213)Bi-18B7 treatment almost completely eliminated colony-forming units from the lung and brain, whereas amphotericin B did not decrease the number of colony-forming units. We conclude that RIT is more effective than amphotericin B against systemic infection with C. neoformans.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / therapeutic use
  • Animals
  • Antibodies, Fungal / therapeutic use
  • Antifungal Agents / therapeutic use*
  • Bismuth / therapeutic use
  • Brain / microbiology
  • Colony Count, Microbial
  • Cryptococcosis / drug therapy*
  • Cryptococcosis / microbiology
  • Cryptococcosis / therapy*
  • Cryptococcus neoformans / isolation & purification*
  • Disease Models, Animal
  • Female
  • Lung / microbiology
  • Mice
  • Radioimmunotherapy / methods*
  • Radioisotopes / therapeutic use
  • Treatment Outcome

Substances

  • Antibodies, Fungal
  • Antifungal Agents
  • Radioisotopes
  • Amphotericin B
  • Bismuth